Random

FDA

FDA Advisory Committee: Weighing Risks and Benefits of Opana ER

Weighing Risks and Benefits of Opana ER

Suzanne B. Robotti

A New Opioid Deterrent Falls Short For FDA

A New Opioid Deterrent Falls Short For FDA

Suzanne B. Robotti

How Imodium Became Appealing to Opioid Addicts

How Imodium Became Appealing to Opioid Addicts

FDA Warning: Side Effects of Injectable Silicone

FDA Warning: Side Effects of Injectable Silicone

FDA Approves First Pill to Treat All Types of Hepatitis C

FDA Approves First Pill to Treat All Types of Hepatitis C

Open Letter to the FDA: You’re Protecting the Wrong People

Su Calls on the FDA to Release the Names of Drugs Approved Using Fraudulent Data

Open Letter to the FDA: You’re Protecting the Wrong People

Suzanne B. Robotti

Heart Failure Drug Rejected, Rejected Again, Then Approved, What’s Up?

MedShadow Articles

Heart Failure Drug Rejected, Rejected Again, Then Approved, What’s Up?

FDA Approves First Direct-to-Consumer Genetic Risk Tests

Tests and Testing

FDA Approves First Direct-to-Consumer Genetic Risk Tests

Issues Related to Healthcare News FDA

FDA warns of heart risk for many common pain relievers

Part 2: The FDA Cracks Down On Stem Cell Therapy

Regenerative Medicine Series

Part 2: The FDA Cracks Down On Stem Cell Therapy

Study Questions Safety of Silicone Breast Implants; FDA Disputes Findings

Study Questions Safety of Silicone Breast Implants

FDA Cracks Down on Online Sellers of Rx Opioids

FDA Cracks Down on Online Sellers of Rx Opioids

Light Therapy May Ease Cancer Symptoms

News FDA Quick Hits

Quick Hits: Light Therapy May Ease Cancer Symptoms

FDA Backlog Keeps Generics From Coming To Market

FDA Backlog Keeps Generics From Coming To Market

Health Pulse FDA

Could the FDA Be Doing More to Curb Teen E-Cig, Vaping Use?

Issues Related to Healthcare News FDA Watch Diabetes News FDA

FDA Issues Warning on Common Diabetes Drugs

FDA: Arsenic in rice won’t harm health immediately

Medshadow Staff

Diflucan May Boost Miscarriage Risk

Diflucan May Boost Miscarriage Risk

Restasis: When Advertising Outweighs Research and Common Sense

Healthy Skeptic 2

Restasis: When Advertising Outweighs Research and Common Sense

Suzanne B. Robotti

FDA

FDA Yanks Approval of Cholesterol Drugs Over Lack of Benefit

Load More

x